Biologic Therapies Summit X and Vasculitis online series
Lupus: Advances in diagnosis and management
Release date: July 13, 2023
Expiration date: July 12, 2025
Estimated Time of Completion: 45 minutes
Session Agenda:
Advances in biologics in lupus
Emily Littlejohn, DO, MPH, Cleveland Clinic
Type 1 versus Type 2 lupus
Jennifer Rogers, MD, Duke Health
Description
Watch Biologic Therapies Summit X and Vasculitis Online Series, on-demand, complimentary webcasts that brings together world leaders in immune-based therapies to address cutting-edge topics in immunology and rheumatology. Education focuses on vasculitis, including key issues in the differential diagnosis of vasculitis, CNS vasculitis, ANCA-associated vasculitis, and organ-specific issues in vasculitis. In addition, the online series features talks on CAR T-cell therapy, irAEs, precision medicine and the next generation of JAK inhibitors for IMIDs, and advances in complement biology and therapy. A deep dive into rheumatoid arthritis, AS, PsA and SpA, infections, COVID-19, co-morbidities with IMIDs, including ILD and cardiovascular risk in immune-mediated diseases, and lupus. Lastly, the CE-certified webcasts address pain management and the exploration of the social and scientific fundamentals of pain.
Disclosures
Cassandra Calabrese, DO | |
Astra Zeneca, Lilly |
Consulting |
Sanofi-Regeneron |
Consulting |
Leonard Calabrese, DO | |
Astra Zeneca, BMS |
Teaching and Speaking |
Novartis, Regeneron, Sanofi Aventis |
Consulting |
Genentech/Roche |
Consulting |
Abbvie Pharmaceuticals, Janssen, UCB |
Consulting |
M. Elaine Husni, MD, MPH | |
Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co, Genzyme/Sanofi, Janssen, Lilly, Regeneron |
Consulting |
Celgene Corporation, Pfizer, Inc. |
Advisor or review panel participant |
Genenetch, UCB, Inc. |
Consulting |
Novartis Pharmaceuticals |
Consulting |
WebMD |
Consulting |
Elizabeth Kirchner, DNP | |
Janssen Pharmaceuticals, Inc. |
Consulting |
RhAPP |
Teaching and Speaking |
Boehringer Ingelheim, Horizon Pharma, UCB |
Advisor or review panel participant |
Carol Langford, MD | |
Astrazeneca Pharmaceuticals |
Other activities from which remuneration is received or expected: Non-paid consultant for research Clinical trial funding support - this has ended |
Bristol-Myers Squibb Co. |
Other activities from which remuneration is received or expected: Clinical trial funding support Non- paid consultant for research |
Chemocentryx, GlaxoSmithKline |
Other activities from which remuneration is received or expected: Clinical trial funding support |
Abbvie Pharmaceuticals |
Other activities from which remuneration is received or expected: Non- paid consultant for research |
Emily Adele Littlejohn, DO | |
Aurinia Pharmaceuticals |
Teaching and Speaking |
Amanda Mixon, PA-C | |
Abbvie Pharmaceuticals |
Consulting |
Eli Lilly, Janssen Pharmaceuticals, Inc |
Advisor or review panel participant |
Amgen |
Teaching and Speaking |
Astrazeneca Pharmaceuticals, RhAPP, Sanofi |
Advisor or review panel participant |
UCB, Inc. |
Consulting |
Jennifer Rogers, MD | |
Abbvie Pharmaceuticals |
Consulting |
Eli Lilly, Janssen Pharmaceuticals, Inc |
Advisor or review panel participant |
Amgen |
Teaching and Speaking |
Astrazeneca Pharmaceuticals, RhAPP, Sanofi |
Advisor or review panel participant |
UCB, Inc. |
Consulting |
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this live activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this enduring activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s R.J Fasenmyer Center for Clinical Immunology.